Australia's most trusted
source of pharma news
Monday, 07 October 2024
Monday, 7 October 2024
Subscribe
Login
News Headlines
News Headlines
News
J&J restructure skirts Australia
Posted 27 September 2024 AM
Updated: Johnson & Johnson is being tight-lipped about the extent to which local employees may be affected by its decision to wind down its cardiovascular and metabolic drug unit globally, however the Australian arm does not market the drug most affected by the change.
The main affected drug is Xarelto, which is sponsored by Bayer in Australia. It earned $140.4 million pre-rebate on the R/PBS in the financial year of 2024, effectively steady from the previous financial year when it earned $142.4 million.
To see the whole article, please login
Posted 27 September 2024 AM
Updated: Johnson & Johnson is being tight-lipped about the extent to which local employees may be affected by its decision to wind down its cardiovascular and metabolic drug unit globally, however the Australian arm does not market the drug most affected by the change.
The main affected drug is Xarelto, which is sponsored by Bayer in Australia. It earned $140.4 million pre-rebate on the R/PBS in the financial year of 2024, effectively steady from the previous financial year when it earned $142.4 million.
To see the whole article, please login
Popular
Latest Jobs
Pharma in Focus Jobs
Marketing & Communications (6)
- Brand Manager - Sydney
- Manufacturing Data Analyst - Blacktown
- Brand Manager - Sydney
- Senior Brand Manager - Sydney
- Senior Brand Manager - Sydney
- Brand Manager - Sydney
Sales & Customer Relations (15)
- Customer Service Representative - St Leonards
- Key Account Manager - Melbourne
- Specialist, Oncology Hospital Sales - NSW
- Specialist, Oncology Hospital Sales - Victoria - VIC
- Assistant Accountant - Melbourne
- Hospital Specialist Representative - Brisbane
- Territory Manager - Capital Equipment - Melbourne
- GP Sales Representative - Brisbane
- Medical Sales Representative - New South Wales
- Customer Service Representative - Mount Waverley
- Hospital Specialist Representative - Sydney
- Customer Service Representative - Sydney
- Customer Service Representative - Frenchs Forest
- Customer Service Representative - Toongabbie
- Salesforce Developer - Sydney
Clinical & Medical, R&D (12)
- Clinical Trials Coordinator - Sunshine Coast
- Clinical Nurse Educator - Sydney
- Medical Science Liaison, Oncology - QLD
- Medical Science Liaison, Ophthalmolgy - QLD
- Clinical Research Nurse - Melbourne
- Senior Preclinical Development Scientist - 12 month contract - Sydney
- Quality Control Microbiologist - Melbourne
- Clinical Site Director - Melbourne
- Clinical Trials Coordinator - Melbourne
- Medical Affairs Associate - Sydney
- Medical Sales Representative - New South Wales
- Senior Clinical Research Scientist - Sydney
Regulatory, Pharmacovigilance & QA (6)
- Quality Control Microbiologist - Melbourne
- Quality Control Chemistry Analyst (Stores) - Parkville
- RA/QA Specialist - Sydney
- Quality Control Virology Analyst - Parkville
- Regulatory Affairs Manager - Sydney
- Quality Assurance Associate - Tullamarine
Other (13)
- HSR - Rare Disease NSW & ACT - Sydney
- Supply Chain Coordinator - Macquarie Park
- Pharmacy Assistant - Brunswick
- Lead, Therapeutic Area Specialty, Women's Health - Australia
- Principal Investigator - Melbourne
- Supply Chain Associate - Macquarie Park
- Principle Investigator - Sydney
- Material Planner / Inventory Coordinator - Tullamarine
- Warehouse Assistant - North Ryde
- Warehouse Assistant - North Ryde
- MSL - Oncology/Haematology - QLD - Brisbane
- EHS Advisor - Blacktown
- Sterility Assurance Specialist - Dallas
MORE NEWS
Email this article to a friend
From:
Print this article
Copyright Notice
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.